Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

Aptose Biosciences (TSE:APS) has released an update. Aptose Biosciences is advancing the development of its promising drug tuspetinib as part ...

Obecabtagene autoleucel (obe-cel; Aucatzyl) has been approved by the FDA to treat patients with relapsed or refractory B-cell ...

Advances in drug discovery, coupled with regulatory approvals for novel drugs like inotuzumab for acute lymphoblastic leukemia, underscore the industry ... regulatory agencies contribute to the timely ...

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

Any type of clonal hematologic malignancy may occur. Myeloproliferative syndrome, myelodysplastic syndrome, and acute myeloid leukemia occur with much higher frequency than non-Hodgkin's lymphomas ...